ATAI Q1 2026 Earnings NarrowerthanExpected Loss as Clinical Pipeline Advances IN8bio Q1 2026 Earnings EPS Beat Drives Modest Stock Gain as Development Costs Remain under Control HOFT Q1 2026 Earnings EPS Misses Estimates Yet Stock Rises on Underlying Strength ORLA Q1 2026 Earnings Slight EPS Miss but Stock Gains 496 PSBD Q1 2026 Earnings Significant EPS Miss Driven by Unrealized Losses Euronet Worldwide EEFT Q1 2026 Earnings EPS Beat Drives Nuanced Outlook Amid Broader Market Headwinds